Yahoo

One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it

The project's database shows that the National Institutes of Health (NIH), part of HHS, terminated grants for projects ...
Fierce Pharma

Gilead’s long-acting PrEP Yeztugo takes off while cell therapy declines continue to haunt sales

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

1 in 5 people have dry mouth, but it’s severely under-diagnosed — here’s what dentists want you to know

Dentists explain what dry mouth is and share the best over the counter treatments. Plus, learn why drinking too much water ...